期刊文献+

经皮肝穿刺胆道支架置放结合动脉化疗栓塞治疗恶性梗阻性黄疸 被引量:17

下载PDF
导出
摘要 目的:观察胆道支架置放结合动脉化疗栓塞姑息治疗恶性梗阻性黄疸的疗效. 方法:对17例恶性梗阻性黄疸患者行经皮肝穿刺胆道支架置放结合动脉化疗栓塞治疗.分别观察血清胆红素下降隋况、手术并发症,并随访胆道支架维持通畅时间和患者生存期. 结果:血清胆红素在术后1 wk下降最快.并发症有疼痛、出血、局限性腹膜炎.17例患者平均支架维持通畅时间为14.2 mo,平均生存期为16.5 mo. 结论:胆道支架置放治疗恶性梗阻性黄疸安全、有效,与动脉化疗栓塞结合可明显延长患者生存期.
出处 《世界华人消化杂志》 CAS 2004年第6期1495-1497,共3页 World Chinese Journal of Digestology
  • 相关文献

参考文献16

  • 1Shao YF. Treatment of proximal biliary duct carcinoma.Zhonghua Zhongliu Zazhi 1992;14:280-283.
  • 2Cucchiara G, Gandini G, Simonetti G, Bracci F, Daffina A.Palliative treatment of extrahepatic bile ducts tumors. J Surg Oncol Suppl 1993;3:154-157.
  • 3Lammer J, Neumayer K. Biliary drainage endoprosthese:experience with 201 placements. Radiology 1986;159:625-629.
  • 4顾万清,郭锦芳.镍钛记忆合金胆道内支撑管在恶性胆道狭窄中的临床应用[J].中华外科杂志,1993,31(5):260-263. 被引量:20
  • 5谢宗贵,张希全,李凡东,金鹏,易玉海,张绪平.胆道支架技术5年回顾(213例随访报告)[J].中华肝胆外科杂志,2002,8(10):595-597. 被引量:78
  • 6胡冰,周岱云,龚彪,钱光相,陈汉,吴孟超.可膨式金属胆道支架解除恶性胆管梗阻的临床应用及其疗效分析[J].中华外科杂志,1999,37(5):282-285. 被引量:48
  • 7Huang DR, Jin XL. Carcinoma of the extrahepatic bile duct.Zhonghua Zhongliu Zazhi 1988;10:67-69.
  • 8Nagahama T, Maruyama M, Nakamura N, Irie T, Yoshida T,Kure N, Ebuchi M. Intrabiliary administration of doxorubicin for pancreaticobiliary cancer. Gan To Kagaku Ryoho 1999;26:1849-1852.
  • 9Shibata T, Sato T, Kondo H, Ootani I, Suzuki H, Kawada S.Two cases of obstructive jaundice due to extrahepatic carcinoma of the bile duct with marked response to daily oral administration of etoposide. Gan To Kagaku Ryoho 1990;17:2429-2432.
  • 10Naoi Y, Suzuki F. Biliary intervention for malignant obstructive jaundice. Treatment through PTCD fistula. Nippon Igaku Hoshasen Gakkai Zasshi 1990;50:1224-1236.

二级参考文献14

  • 1李常茂,袁曙光,闫东,孙勇,范承经,韩正林,普成荣.恶性胆道梗阻的双介入治疗[J].临床医学影像杂志,1996,7(2):79-81. 被引量:5
  • 2谢宗贵 魏敏 等.经皮经肝胆道介入性操作并发症分析与处理[J].介入医学杂志,1997,2:124-126.
  • 3Singh SM,Longmire WP,Reber HA.Surgical plliation for pancreatic cancer[J].Ann Sur,1990,212(2):132-136.
  • 4Smith AC,Douseff JF,Russell RCG,et al.Stent or Surgery for palliation of malignant biliary obstruction.Is the choice clear now?[J].Gastronenterostony,1995,109(4):1398-1400.
  • 5Lopera JE,Soto JA,Munera F.Malignant hilar and perihilar biliary obstruction:use of mr cholangiography to define the extent of biliary ductal involvement and plan percutaneous interventions[J].Radiology,2001,220(1):90-96.
  • 6Lammer J,Hausegger KA,Fluckiger F,et al.Common bile duct obstruction due to malignancy:treatment with plastic versus metal stents[J].Radiology,1996,201(1):167-172.
  • 7Gordon RI,Ring EJ,LaBerge JM,et al.Malignant biliary obstruction:treatment with expandable metallic stent-follow-up of 50 onsecutive patient[J].Radiology,1992,182(3):697-701.
  • 8Schima W,Prokesch R,Osterreicher C,et al.Biliary wallstent endoprosthesis in malignant hilar obstruction:long-term results with regard to the type of obstruction[J].Clin Radiol,1997,52(3):213-219.
  • 9Oikarinen H,Leinonen S,Karttunen A,et al.Patency and complications of percutaneously inserted metallic stents in malignant biliary obstruction[J].J Vasc Interv Radiol,1999,10(10):1387-1393.
  • 10Nakamura T,Kitagawa M,Takehira Y,et al.Polyurethane-covered Wallstents to recanalize Wallstents obstructed by tumor ingrowth from malignant common bile duct obstruction[J].Cardiovasc Intervent Radiol,2000,23(2):161-164.

共引文献147

同被引文献105

引证文献17

二级引证文献116

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部